Pharmaceutical Industry

Page 26 of 100

Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Health

Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug

By
July 8, 2021
Cures for many rare diseases might already exist. Why aren’t we using them?
Commentary

Cures for many rare diseases might already exist. Why aren’t we using them?

By
July 5, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
Health

Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s

By Suzi Ring and Bloomberg
July 2, 2021
States step up push to regulate pharmacy drug brokers
Health

States step up push to regulate pharmacy drug brokers

By Katheryn Houghton and Kaiser Health News
June 30, 2021
Want cheaper insulin? Try Walmart

Want cheaper insulin? Try Walmart

By
June 29, 2021
Intellia CRISPR gene editing stock science
Health

We can now edit genes inside the body. That sent this biotech’s stock soaring

By
June 29, 2021
COVID Delta Delta plus variants
Newsletters

The delta between the Delta variants

By
June 24, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health

Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows

By
June 22, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech

British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company

By
June 15, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health

Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?

By
June 9, 2021
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
Health

Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer

By Cristin Flanagan and Bloomberg
June 9, 2021
Amazon begins offering six-month prescriptions for as low as $6
Health

Amazon begins offering six-month prescriptions for as low as $6

By
June 8, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health

FDA approves Biogen’s controversial Alzheimer’s drug in historic decision

By
June 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health

President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals

By
May 25, 2021
Colorado lawmakers wage multi-front assault on high drug costs
Health

Colorado lawmakers wage multi-front assault on high drug costs

By Markian Hawryluk and Kaiser Health News
May 24, 2021

Most Popular